Skip to main content
. 2020 Oct 12;8(2):e001486. doi: 10.1136/jitc-2020-001486

Figure 3.

Figure 3

Types of cancer being targeted in oncolytic virus (OV) clinical trials. The histological type of cancer being treated by OVs in clinical trials is shown by (A) number of clinical studies and by (B) patients enrolled. Melanoma and GI cancers were the most common. CSCC, cutaneous squamous cell carcinoma; GI, gastrointestinal; N.S., not specified; NOS, not otherwise specified.